Identification of the Extracellular Matrix Binding Sites for Insulin-like Growth Factor-binding Protein 5
Open Access
- 1 June 1996
- journal article
- Published by Elsevier
- Vol. 271 (23) , 13523-13529
- https://doi.org/10.1074/jbc.271.23.13523
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Glycosaminoglycans inhibit degradation of insulin-like growth factor- binding protein-5Endocrinology, 1994
- Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5Endocrinology, 1994
- Synthetic peptide inhibitors of complement serine proteases—III. Significant increase in inhibitor potency provides further support for the functional equivalence hypothesisMolecular Immunology, 1991
- Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de‐endothelialization and repairJournal of Cellular Biochemistry, 1991
- Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.The Journal of cell biology, 1989
- Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like moleculesBiochemistry, 1989
- Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesisNature, 1988
- Structure And Biology Of ProteoglycansAnnual Review of Cell and Developmental Biology, 1988
- Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.Journal of Clinical Investigation, 1987
- Solid Phase Peptide Synthesis. II. The Synthesis of BradykininJournal of the American Chemical Society, 1964